Presentation Features Labcorp’s Combined Oncology Diagnostic and Drug Development Platform for Clinicians and Biopharmaceutical CompaniesBURLINGTON, N.C. (BUSINESS WIRE) Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the vir.